United States · FDA National Drug Code directory

Arranon

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0078-0683_b1a3f864-56e1-44da-b2d0-7158d0945513
Product NDC
0078-0683
Form
INJECTION
Composition / generic term
nelarabine
Labeler
Novartis Pharmaceuticals Corporation
Marketing category
NDA
Marketing start / end (source format)
20161005 / 20260930

Source-listed ingredients

  • NELARABINE — 5 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 50 mL in 1 VIAL (0078-0683-61) · 0078-0683-61

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →